Package 0002-8980-05

Brand: rezvoglar kwikpen

Generic: insulin glargine-aglr
NDC Package

Package Facts

Identity

Package NDC 0002-8980-05
Digits Only 0002898005
Product NDC 0002-8980
Product ID 0002-8980_a9e95b4c-e280-4bef-a3dd-4907bfad6b4d
Description

5 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01)

Marketing

Marketing Status
Marketed Since 2021-12-17
Brand rezvoglar kwikpen
Generic insulin glargine-aglr
Sample Package No

Linked Drug Pages (1)

Rezvoglar KwikPen ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "a9e95b4c-e280-4bef-a3dd-4907bfad6b4d", "openfda": {"nui": ["M0011417", "N0000175453"], "unii": ["2ZM8CX04RZ"], "rxcui": ["2589008", "2589014"], "spl_set_id": ["f6af8706-2058-4fe1-99c8-43684c20bfa2"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE in 1 CARTON (0002-8980-05)  / 3 mL in 1 SYRINGE (0002-8980-01)", "package_ndc": "0002-8980-05", "marketing_start_date": "20211217"}], "brand_name": "Rezvoglar KwikPen", "product_id": "0002-8980_a9e95b4c-e280-4bef-a3dd-4907bfad6b4d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Insulin Analog [EPC]", "Insulin [CS]"], "product_ndc": "0002-8980", "generic_name": "Insulin glargine-aglr", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rezvoglar", "brand_name_suffix": "KwikPen", "active_ingredients": [{"name": "INSULIN GLARGINE", "strength": "100 [iU]/mL"}], "application_number": "BLA761215", "marketing_category": "BLA", "marketing_start_date": "20211217", "listing_expiration_date": "20261231"}